4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-045696
Co-Chief Executive Officer acquired 179,850 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2024-04-16 | Grant or award | +179,850 | 3,202,852 | D | ||
| Derivatives | |||||||
| Cohen Joshua B Co-Chief Executive Officer | 2024-04-16 | Grant or award · Stock Option (right to buy) | +380,000 | 380,000 | D | ||
Loading xslF345X05/ownership.xml…